Infection Control Today - 10/2004: References

REFERENCES

NO SMOKING ALLOWED: ADDRESSING THE DANGERS OF ESU/LASERPLUME AND SURGICAL FIRES IN THE OR, BY KRIS ELLIS, PAGE 12.

1. NIOSH Hazard Control/Control of Smoke form Laser/ElectricSurgical Procedures-HC11.

2. Barrett WL, Garber SM. Surgical Smoke: A Review of theLiterature. Is This Just a Lot of Hot Air? Surg Endosc.17(6):979-87, 2003.

3. Hallmo P, Naess O. Laryngeal Papillomatosis with HumanPapillomavirus DNA Contracted by a Laser Surgeon. EurArch Otorhinolaryngol. 248(7):425-7, 1991.

4. Garden JM, et al. Viral Disease Transmitted byLaser-Generated Plume (Aerosol). Arch Dermatol.138(10):1303-7, 2002.

5. Hazard of Laser Surgery Smoke. OSHA Hazard InformationBulletin. April 11, 1988.

6. Lanfranchi JA. Smoke Plume Evacuation in the OR. AORN J. 65(3):627-33, 1997.

7. McCarthy PM. Fire in the ORDeveloping a Fire SafetyPlan. AORN J. 79(3):588-97.

MANUFACTURERS OF STERILIZATION CASES AND TRAYS ARE WORKINGTOWARD THE SAME PATIENT-SAFETY GOAL, BY DAVID C. FURR, PAGE 16.

1. 21 Code of Federal Regulations §880.6850.

2. FDA Draft Guidance, Premarket Notification [510(k)]Submissions for Medical Sterilization Packaging Systems in Health CareFacilities; Draft Guidance for Industry and FDA: March 7, 2002.

3. AAMI Committee Draft, AAMI/CDV-1, ST77, Containment devicesfor reusable medical device sterilization. Feb. 10, 2004.

INFECTION PREVENTION THROUGH PROPER HAND HYGIENE ANDGLOVING. BY KELLY M. PYREK, PAGE 28.

1. MMWR. Guideline for Hand Hygiene in the Healthcare Setting.Oct. 25, 2002. Vo. 51, No. RR-16.

2. FirstHand. Critical Glove Barrier Issues. Kimberly-ClarkHealth Care.

3. Klein RC, Party E, and Gershey EL. Virus penetration ofexamination gloves. BioDiagnostics Report.

ITS TIME TO BREAK THE MOLD, BY MARY JO VESPER ANDSTEPHEN VESPER, PAGE 44.

1. Perfect, J, Cox GM, Lee JY, Kaufmann, CA, de Repentigny L,Chapman SW, Marrison VA, Pappas P, Hiemenz JW, Stevens DA and Mycoses StudyGroup. The impact of culture isolation of Aspergilllus species: a hospital basedsurvey of aspergillosis. Clinical Infectious Diseases. 33:1824-1833. 2001.

2. Rapp, RP. Changing strategies for the management ofinvasive fungal infections. Pharmacotherapy. 24:4S-28S. 2004.

3. Thio CL, Smith D, Merz WG, Streifel, AJ, Bova, G, Gay L,Miller CB, Perl TM. Refi nements of environmental assessment during an outbreakinvestigation of invasive aspergillosis in leukemia and bone marrow unit. InfectControl Hosp Epidemiol. 21:18-23. 2000.

4. Morrison J, Yang C, Lin K-T, Haugland RA, Neely AN, VesperSJ. Monitoring Aspergillus species by quantitative PCR during construction of amulti-story hospital building. Journal of Hospital Infection. 57: 85-87. 2004.

5. Neely AN, Gallardo V, Barth E, Haugland RA, WardenG, VesperSJ. Rapid monitoring by QPCR for pathogenic Aspergillus during carpet removal from ahospital. Infect Control and Hosp Epidemiol. 25:350-352. 2004.

6. Gerson SL, Parker P, Jacobs MR, et al. Aspergillosis due tocarpet contamination. Infect Control Hosp Epidemiol.1994;15:221-223.

7. Anaissie EJ, Stratton SL, Dignani MC, Summerbell RC, RexJH, Monson TP, Spencer T, Kasai M, Francesconi A, and Walsh TJ. Pathogenic Aspergillus speciesrecovered from a hospital water system. Clinical InfectiousDiseases. 34:780-789. 2002.

8. Brinkman NE, Haugland RA, Wymer LJ, Byappanahalli M,Whitman RL, Vesper SJ. Evaluation of a Rapid, Quantitative Real-Time PCR Method for CellularEnumeration of Pathogenic Candida Species in Water. Applied andEnvironmental Microbiology. 69:1775-1782. 2003.

9. Richardson MD, and Warnock DW. Asperillosis. In: FungalInfection: Diagnosis and Management, 3rd Ed. Blackwell Publishing, Malden, Mass. 2003.

THIS JUST IN: HEADLINES IN DISINFECTION AND STERILIZATION,BY JOHN ROARK, PAGE 50.

1. www.fda.gov/cdrh/Reuse/reuse-messages.html. Referenced Aug.9, 2004.